Aimco Pesticides

- The company has assured purchase orders for the inventory built due to deferred deliveries, expecting normalization in coming quarters (Page 3). - Contract manufacturing revenue from the segment is currently around ₹120-125 crore per quarter, with projections for increase once higher capacity production comes online (Pages 10, 13). - Production capacity planned to scale from current ~100-125 tons/month to 300 tons starting January 2023, later increasing to 500 tons (Pages 12,13). - Early projections from contract manufacturing customers look very strong with confidence to achieve up to ₹80 crore revenue (Pages 12, 13). - Some deliveries deferred due to the seasonal nature of products and customers awaiting free trade agreement implementations (Pages 4, 8). - Outlook for H2 FY23 is tapered down due to subdued demand but optimistic for FY24 with additional capacity and new market registrations (Pages 3-4).

- There is no explicit mention of any current or future fundraising plans through debt or equity in the provided transcript of Aimco Pesticides Limited's Q2 FY23 earnings conference call. - The discussions primarily focus on operational aspects, production capacity expansion, product registrations, demand outlook, and contract manufacturing growth. - No direct references were made regarding plans for raising capital via debt or equity during the call or in the related disclosures.

- Aimco Pesticides Limited has undertaken a capacity expansion project, expected to conclude by January 2023, increasing monthly production capacity to 500 metric tons. - There are delays in implementing the increased production capacity, now expected to start from January 2023 and stabilize over a couple of months. - The company is planning to initiate production at 300 tons capacity starting January 2023 and eventually ramp up to 500 tons during the year. - Two new products (one insecticide and one herbicide) are in the pipeline, with manufacturing decisions dependent on receiving registrations from certain markets; specific timelines are not confirmed yet. - The company has increased depreciation due to higher capital expenditure (CapEx) related to expansion. - No mention of other strategic investments beyond capacity expansion and product pipeline development during the call.

- Aimco Pesticides expects business operations to pick up from FY24 onwards with additional capacity coming on stream post-expansion in Q4 FY23. - The company is optimistic about demand projections for FY24, supported by new product registrations in emerging markets and early customer projections. - Contract manufacturing revenue is anticipated to increase significantly once higher production capacity (500 tons monthly) is stabilized from January 2023. - Production scale-up is planned from current 100-125 tons/month to 300 tons starting January 2023, eventually reaching 500 tons. - Despite subdued demand in H2 FY23, strong projections and secured purchase orders support future growth. - New product introductions (one insecticide and one herbicide) are in the pipeline, expected to contribute to future revenue. - The company targets steady-state EBITDA margins between 7%-9% upon normalization of demand.

- Aimco expects business operations to pick up with utilization of new production capacity of 500 MT/month from January 2023 onwards. - Early projections from customers for FY24 are very strong, supporting optimism for growth. - The company aims to achieve steady-state EBITDA margins between 7% to 9%, improving from current lower margins caused by subdued demand. - Contract manufacturing revenue is expected to scale up from around ₹20 crore per quarter to ₹80 crore, with production capacity being expanded to 300 tons initially and later to 500 tons. - New product registrations in markets like Brazil are expected by March 2023, potentially adding 50-60 MT/month business from FY24. - FY23 outlook is tapered down due to subdued demand and deferral of orders, but FY24 guidance remains optimistic with expected growth. - Demand recovery and tariff benefits (e.g., Australia free trade agreement) are expected to further boost earnings from FY24 onwards.